Myasthenia gravis is best described as an autoimmune disorder affecting what at the neuromuscular junction?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Myasthenia gravis is an autoimmune condition in which antibodies attack the postsynaptic acetylcholine receptors at the neuromuscular junction. This reduces the number of available receptors, so acetylcholine released from the motor neuron is less able to depolarize the muscle fiber, weakening transmission across the junction. The result is fatigable muscle weakness that worsens with activity and improves with rest. The other options don’t fit because myelin sheaths are involved in central and peripheral demyelinating diseases, GABA receptors are part of inhibitory signaling in the CNS, and sodium channels are key for action potential generation but are not the primary target in MG. Treatments work by increasing acetylcholine availability and modulating the autoimmune response, such as with acetylcholinesterase inhibitors and immunosuppressive therapies.